Lancet to sell African laboratories for $123m

Cerba, a Paris-based medical company, will hold a 51% stake in a joint venture with Lancet

Ascendis shares bounce as forced sales slow

Private equity firm Coast2Coast has been offloading the company's shares to meet margin calls

Alternative reimbursement in the private healthcare sector

SPONSORED | Medshield’s proposed alternative reimbursement model focuses on being more cost effective

Ascendis investor Coast2Coast works to end forced share sales

Coast2Coast has been offloading Ascendis shares in recent weeks to meet obligations to lenders

Drug maker GSK to split after folding in Pfizer consumer unit

The new joint venture with Pfizer is expected to generate total annual cost savings of £500m by 2022

Aspen issues clarification after share falls 9%

Changes to its debt covenant if it fails to conclude the €740m sale of its nutritionals business to Lactalis by the end of the year alarmed investors

Aspen could sell portfolio for R1.9bn

US-headquartered pharmaceutical group Mylan will have option to buy portfolio

Discovery takes aim at market inquiry over Remgro interests

SA’s biggest medical scheme wants an assertion about possible anti-competitive behaviour to be withdrawn

Netcare cries foul over Discovery executive’s involvement in market inquiry

The involvement of a Discovery Health executive in the Competition Commission's probe into the healthcare market has stirred a hornet’s nest

Lower drug sales potential at Bayer underscores the need for deals

The conglomerate faces a threat to revenues in 2024 when the patent on blockbuster heart drug Xarelto runs out

Opioid case promises huge dose of pain for Insys Therapeutics

Former top sales executive at Insys Therapeutics Alex Burlakoff is one of the first charged in the mounting legal backlash to the US opioid epidemic

GSK to buy cancer drugmaker Tesaro for $5.1bn

Britain’s largest drugmaker is paying $75 a share for the business, a 110% premium to the 30-day average price

New FHI study reveals connected-care technology could be missing link in SA value-based healthcare

SPONSORED | SA’s health system value measure is below the 16-country average

Life Healthcare continues to impress under new CEO

Life Healthcare delivers strong financial results, reporting solid revenue and earnings growth

WATCH: Life Healthcare delivers strong full-year performance

Life healthcare has delivered solid annual numbers and the group’s CEO Shrey Viranna joined Business Day TV for more perspective on the year that was.

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.